Introduction
A large amount of evidence from cellular and animal studies, 1 and from clinical trials, 2 -5 suggested that an increased intake of fish oil fatty acids has favourable effects on cardiovascular health. Analyses of these trials concluded that these beneficial effects mainly occur through the prevention of sudden cardiac death, which is often preceded by ventricular arrhythmias, indicating that polyunsaturated fatty n-3 acids (PUFAs) are antiarrhythmic. 3, 6 However, not all studies have demonstrated the cardioprotective effects on cardiovascular diseases of PUFA consumption. Pro-arrhythmic actions have been described for PUFAs in animal models during acute regional myocardial ischaemia. 7 Moreover, the recent Alpha OMEGA and OMEGA randomized trials, involving patients who suffered myocardial infarction, did not show any improvement in the clinical results following PUFA supplementation, 8, 9 and even a deleterious effect due to an increased risk of cardiac death was reported in men with stable angina who were advised to eat fish, 10 or in patients with implantable cardioverter defibrillators. 11 These differences could be explained by the fact that a diet rich in fish oil could be pro-or antiarrhythmic depending on the underlying arrhythmogenic mechanism. 12 In any case, the mechanism underlying the pro-or antiarrhythmic effect after supplementation is thought to be related to the modulation of the cardiac ion channels involved in the genesis and/or maintenance of cardiac action potentials (APs). Indeed, PUFAs decrease I Na , I Kur , I to , I Kr , I CaL , and I NCX , and enhanced I Ks and I K1 . 13 -19 K v 7.1 and KCNE1 are the two major pore-forming and ancillary subunits, respectively, responsible for the biophysical properties of I Ks channels. 20 Doolan et al. demonstrated that eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) do not modify the electrophysiological characteristics of K v 7.1 channels, although DHA, but not EPA, increases the magnitude of the K v 7.1/KCNE1 current in Xenopus oocytes, effect mediated by the KCNE1 subunit. 16 In cardiac myocytes from pigs fed with a PUFA enriched-diet, I Ks magnitude was greater than that recorded in myocytes from control animals. 21 However, the precise mechanism by which PUFAs produce these effects on K v 7.1/KCNE1 channels remains to be elucidated.
Methods

Cell transfection
In acute experiments, transfection of pCDNA3.1 KCNQ1/KCNE1 concatemer (human KCNE1 linked to the N-terminus of the human KCNQ1) in COS7 cells was performed with Fugene6, following manufacturer's instructions. In the rest of experiments, cells were transfected with KCNQ1-YFP and KCNE1-CFP.
Preparation of cell extracts
COS7 cultures were washed twice with ice-cold PBS. Cells were homogenized and cell extracts were prepared as described in Supplementary material online, Methods.
Western blot analysis
Samples of cell extracts containing equal amounts of protein were boiled in Laemmli SDS loading buffer (250 mM Tris -HCl, pH 6.8, 2% SDS, 10% glycerol, and 2% b-mercaptoethanol) and size-separated in 7 -10% SDS -PAGE. The gels were blotted onto PVDF or nitrocellulose membranes and processed as recommended by the supplier of the antibodies (see Supplementary material online, Methods).
Lipid rafts
Low-density, Triton-insoluble complexes were isolated as previously described from transfected COS7 cells. 22 Cells were homogenized in 1 mL of 1% Triton X-100 and sucrose was added to a final concentration of 40%. A 5 -30% linear sucrose gradient was layered on top and further centrifuged (260 000 g) for 20-22 h at 48C in a Beckman SW41 rotor. Gradient fractions (1 mL) were collected from the top and analysed by western blotting.
Electrophysiological recordings
Currents were recorded using the perforated amphotericin B or whole-cell patch-clamp technique with an Axopatch 200B amplifier (Axon instruments) as described. 23, 24 The investigation conforms to the NIH guidelines (Guide for the Care and Use of Laboratory Animals; NIH publications number 23 -80) revised in 2011; and from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes and approved by the University of Milano-Bicocca ethics review board. Adult Dunkin-Hartley guinea pig was anesthetized by 100 mg/kg sodium thiopental (Sigma Aldrich, St Louis, MO, USA) and euthanized by cervical dislocation. Guinea pig ventricular myocytes were isolated as previously described. 25 Membrane cholesterol depletion was achieved by methyl-b-cyclodextrin (MbCD) treatment (2 mM).
Statistical analysis
Data are presented as mean values + SEM. Paired or unpaired Student's t-test or repeated-measures ANOVA followed by the Bonferroni test. A value of P , 0.05 was considered statistically significant.
Computational modelling
The K v 7.1/KCNE1 current was described by a Markov model, whose transition rates were set by fitting the experimental recordings obtained in the different conditions. The current formulation was then inserted into the O'Hara-Rudy model of human ventricular action potential. An expanded description is available in Supplementary material online, Methods.
Results
3.1 EPA and DHA increase K v 7.1/KCNE1 current EPA or DHA concentration (20 mM) used in this study was selected on the basis of the free fatty acid levels in the plasma of six patients included in the SOFA trial 26 who were taking 2 g/day fish oil. They exhibited concentrations of free EPA and DHA of 10 mM (5.0-16.4 mM) that accumulate in atria at expenses of arachidonic acid from phospholipids. Figure 1A shows K v 7.1/KCNE1 recordings obtained after applying 12 s pulses from a holding potential of 280 to +60 mV in the absence and in the presence of EPA or DHA. Both PUFAs increased the current by 37.3 + 6.2% (P , 0.05, n ¼ 13) and 82. Tail currents were elicited upon repolarization to 240 mV after each voltage step. An increase in the tail current magnitude of 26.5 + 14.6% (P , 0.05, n ¼ 14) and 27.3 + 13.3% (P , 0.05, n ¼ 9) after exposure Polyunsaturated fatty acids and K v 7.1/KCNE1 channels to EPA or DHA was observed ( Figure 1C) . Under control conditions, the deactivation exhibited monoexponential kinetics. However, in the presence of either PUFA, this kinetics became biexponential (see Supplementary material online, Table S1 ). Figure 2A shows current recordings obtained in the absence and presence of EPA when applying 5.5 s pulses from 280 to +60 mV in 10 mV steps from a holding potential of 280 mV. EPA (20 mM) increased the amplitude of the current at all membrane potentials tested positive to 210 mV ( Figure 2B ) and shifted the V mid of the activation curve towards more negative potentials (+22.3 + 6.6 vs. +13.5 + 5.5 mV, P , 0.05, n ¼ 5) without modifying the slope (16.7 + 1.3 vs. 18.6 + 1.7 mV, P . 0.05, n ¼ 5; Figure 2C ). Figure 2D shows the relative current in the presence of EPA vs. the membrane potential. The maximal increase occurred at 0 mV. This effect might be due to the negative shift of the activation curve, suggesting that the primary mechanism of the increased magnitude of K v 7.1/KCNE1 may be due to an effect on channel gating. Similar qualitative effects were produced by DHA (see Supplementary material online, Figure S1 ).
It has been described that the slow gating of I Ks is likely due to the fact that KCNE1 accessory subunit slows the movement of the voltage sensors. To determine that the concatemeric construction does not interfere with the normal properties of I Ks and also to analyse the effects of EPA and DHA, a series of experiments in which the currents were recorded in COS7 cells co-transfected with KCNQ1-YFP and KCNE1-CFP were performed. As shown in Supplementary material online, Figure S2 , the effects produced by EPA/DHA on I Ks were similar than those observed in cells transfected with the concatemer KCNQ1/KCNE1 subunits. The only difference observed was that the activation kinetics of the K v 7.1/KCNE1 current became monoexponential (see Supplementary material online, Tables S2 -S4) .
Effects of PUFAs were also evaluated on native I Ks recorded in guinea pig ventricular myocytes at 368C. I Ks was recorded at +20 mV under I CaL and I Kr blockade by nifedipine (10 mM) and E-4031 (5 mM), respectively. A total of 14 myocytes were analysed. In 11 myocytes, DHA (10 mM) increased I Ks amplitude (+37.7 + 6%, P , 0.05) and accelerated its deactivation at 240 mV (t 1/2 219.1 + 8%, P , 0.05, see Supplementary material online, Figure S3 ). However, in 5 of 11 myocytes, during long-time recordings, the initial increase of I Ks was followed by a progressive decrease in the current. Moreover, in three myocytes, exposure to 10 mM DHA was directly followed by a decline in I Ks amplitude (data not shown).
3.2 Acute vs. chronic effects of EPA and DHA on K v 7.1/KCNE1 current An increased consumption of PUFAs leads to increased blood and tissue levels of PUFAs. 26 However, the relative contribution of short-and longterm administration on the electrophysiological effects on ion currents has not been determined. Since we wished to analyse and relate the electrophysiological effects with the effects on the levels of expression and also targeting to the lipid rafts, the same conditions were used in all these experiments: COS7 were co-transfected with KCNQ1-YFP and KCNE1-CFP for 48 h with 20 mM EPA/DHA in serum-free medium. Controls of these experiments were COS7 cells cotransfected with KCNQ1-YFP and KCNE1-CFP incubated for 48 h in serum-free medium without EPA/DHA. To differentiate the acute from the possible chronic effects of EPA and DHA, three different approaches were used. First, we analysed the electrophysiological properties of K v 7.1/KCNE1 Figure 3C and see Supplementary material online, Figure S4C ). EPA induced a positive shift of the activation curve (V mid ¼ 21 + 3 vs. 31 + 3 mV, P , 0.05, n ¼ 14 -7, for control and chronic EPA, respectively; Figure 3D ). However, DHA shifted the activation curve to negative potentials (V mid ¼ 21 + 3 vs. 13 + 4 mV, P , 0.05, n ¼ 14 -12, for control and chronic DHA, respectively). Thus, chronic EPA and DHA produce different effects in the channel voltage-dependence. Chronic treatment with EPA and DHA, but not with a-linolenic acid, decreases the protein levels of K v 1.5 in L-cells. 19 Thus, our second approach was to analyse whether chronically applied EPA and DHA modified the expression pattern of K v 7.1 and KCNE1 subunits. To that end, COS7 cells were transfected with K v 7.1-YFP alone or together with KCNE1-CFP, and the levels of K v 7.1 and KCNE1 were measured by western blot. Under both experimental conditions, EPA reduced the protein levels of K v 7.1 in a concentration-dependent manner ( Figure 4A ), but not those of KCNE1 ( Figure 4C ). Internalization and stability of K v 7.1 is regulated by ubiquitylation, 27 and PUFAs are able to modify the activity of the proteasome. Thus, the decrease in K v 7.1 protein level might be due to a higher degree of K v 7.1 degradation via proteasome. Hence, a series of experiments in the presence of 2 mM MG132 (proteasome inhibitor) were performed. Under these experimental conditions, EPA did not produce any change in the protein levels of K v 7.1, thus suggesting that EPA induces degradation of K v 7.1 via proteasome ( Figure 4B ). Similar results were obtained for DHA (see Supplementary material online, Figure S5 ). K v 7.1 and KCNE1 subunits partially target to lipid rafts in HEK-293 cells and ventricular myocytes. 22, 28 Dietary PUFAs incorporate into the cell membrane and, by altering the lipid composition and protein distribution of lipid raft microdomains, may affect ion channel function. 21 Therefore, the third approach was to analyse whether EPA and DHA modified the location of K v 7.1 and/or KCNE1 in lipid rafts. Figures 4D and see Supplementary material online, Figure S5D show the distribution of K v 7.1 and KCNE1 over the sucrose gradient under control conditions and after incubation with EPA or DHA for 48 h. Both PUFAs altered the buoyancy of cholesterol-enriched domains as indicated by a redistribution of caveolin thorough the gradient. Concomitantly, the localization of K v 7.1 and KCNE1 was also varied, indicating different channel localization in membrane microdomains. A spatial redistribution of K v 7.1 and KCNE1 in the membrane surface can account for some of the electrophysiological changes observed on K v 7.1/KCNE1.
Effects of cholesterol depletion on K v 7.1/KCNE1 current
Association with lipid rafts is an important signalling mechanism for ion channel function and changes and disruption of these microdomains modify the activity of ion channels.
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Because PUFAs modified the localization of K v 7.1 channels in lipid microdomains, we analysed the electrophysiological consequences of the disruption of these structures (by removing cholesterol from the membrane with MbCD) on K v 7.1/KCNE1. COS7 cells were sequentially perfused with different external solutions in the following order: (i) normal external solution; (ii) 10 mM MbCD; (iii) 10 mM MbCD + 20 mM EPA, and (iv) drug-free external solution with 10 mM MbCD. MbCD triggered an increase in the K v 7.1/KCNE1 current at potentials positive to +30 mV and a decrease in the current at potentials negative to +30 mV ( Figure 5A-D) . Concomitantly, a positive shift of the activation curve approximately +23 mV (P , 0.05, n ¼ 4) was observed (Figure 5D and E; see Supplementary material online, Table S5 ). Under these conditions, perfusion with EPA produced similar effects than those observed in cells non-treated with MbCD. Thus, (i) an increase in the current at potentials negative to +40 mV; (ii) no changes in the midpoint of the activation curve compared with that obtained in the presence of MbCD; and (iii) an increased slope factor. EPA effects were accompanied by the typical slowing of the activation kinetics that was due to the abolishment of the fast component of the activation process (see Supplementary material online, Table S6 ) and the appearance of a second component in the deactivation processes, becoming again biexponential. EPA effects produced in cholesterol-depleted cells with MbCD were reversible, not only in the magnitude of the current, but also in the kinetics and in the activation curve ( Figure 5 ).
Computational modelling of the experimental results
A Markov model of the human K v 7.1/KCNE1 channel 30, 31 was optimized to reproduce PUFA acute effects observed in K v 7.1/KCNE1, within the same model structure, by adjusting the parameters governing the transitions between the different channel states (see Supplementary material online, Figures S6 -S8) and, for the case of chronic exposure to EPA, the maximal current conductance (see Supplementary material online, Figure S6D ). Model simulations of K v 7.1/KCNE1 current reproduced accurately the experimental current traces under voltage clamp (see Supplementary material online, Figure S6 ) as well as current-voltage and tail current-voltage relationships (see Supplementary material Polyunsaturated fatty acids and K v 7.1/KCNE1 channels online, Figure S8 ). The K v 7.1/KCNE1 current model was incorporated into a biophysically detailed model for human ventricular epicardial cell AP by O'Hara et al., 32 which has a basal AP duration measured at the 90% repolarization (APD 90 ) of 226 ms. The main effects of the altered parameters during an AP are shown in Figure 6 , and the effects on the closed zones occupancy are detailed in Supplementary material online, Figure S9 . PUFAs increased the open state probability of the K v 7.1/KCNE1 channel, leading to an elevated K v 7.1/KCNE1 current during the AP, and slightly shortened the APD 90 ( Figure 6 ). The APD 90 in the presence of EPA and DHA was 214 and 217 ms, respectively. These observations are also reflected in the simulated S1-S2 restitution ( Figure 6A) . On the contrary, chronic EPA did not significantly altered K v 7.1/KCNE1 when compared with control, and therefore expectedly did not alter the APD 90 .
PUFA effects on K v 7.1/KCNE1 current were simulated in a condition in which the contribution of K v 7.1/KCNE1 channels to repolarization can be more critical. Indeed, along with their effects on K v 7.1/KCNE1 channels, acute and chronic exposure to PUFAs affects K v 11.1 current. The effects of a graded reduction in K v 11.1 were simulated. K v 7.1/KCNE1 and K v 11.1 current profiles during AP and APD 90 are illustrated in Figure 7 . EPA and DHA partially compensated the AP prolongation due to K v 11.1 reduction, whereas the chronic exposure had negligible effects for K v 11.1 reductions up to 60% but led further AP prolongation for 80% K v 11.1 block. The relative shortening of APD 90 due to EPA in comparison with control APD 90 was greater as the K v 11.1 block was increased. At a 20% block of K v 11.1, EPA reduced APD 90 to 93.1%, whereas DHA reduced APD 90 to 95.3%. At 80% block of K v 11.1, EPA reduced APD 90 to 83.7%, whereas DHA reduced APD 90 to 94.1%.
Discussion
In this study, we investigated the effects of two n-3 PUFAs from marine origin (EPA and DHA) on K v 7.1/KCNE1 channels expressed in COS7 cells and on I Ks in guinea pig cardiomyocytes. We demonstrated that: (i) at physiological concentrations, both PUFAs increase the magnitude of K v 7.1/KCNE1 current after acute, but not after chronic, exposition, DHA being more potent than EPA. 
Acute and chronic effects of n-3 PUFAs
In this study, we demonstrated that acute perfusion of EPA or DHA increased to a different extent the magnitude of K v 7.1/KCNE1 current. EPA and DHA increased the current and slowed its activation kinetics. Moreover, their effects on the electrophysiological properties of this current exhibited some differences, which are consistent with a direct effect of both PUFAs with these channels. These results can be due to a modification of the interaction between KCNE1 and K v 7.1 subunits, without changes in stoichiometry, since similar effects were observed in cells transfected with the concatemer KCNQ1/KCNE1 construction and cells co-transfected with the two subunits separately. Also, as previously described, 16 neither EPA nor DHA modified the properties of K v 7.1 channels when expressed alone (see Supplementary material online, Figure S10) . Thus, the presence of KCNE1 subunits is essential for the observed electrophysiological effects of acutely applied PUFAs. Dietary administration of fish oil leads to the incorporation of PUFAs into the cell membranes. 21 It has been reported that long-term PUFA intake modulates the activity of several cardiac ion channels. However, the effects of long-term administration of PUFAs differ from those observed after acute administration. In this line of evidence, the effects of long-term administration of EPA and DHA (48 h) on COS7 cells expressing K v 7.1/KCNE1 channels were different compared with those produced acutely. Chronic application of EPA or DHA did not increase the current magnitude, but it accelerated the activation process compared with acutely EPA effects. Surprisingly, EPA and DHA shifted the activation curve towards opposite directions, suggesting that the mechanism by which acute or chronic PUFA modulates the electrophysiological properties of K v 7.1/KCNE1 channels is different.
Direct and indirect effects on K v 7.1/KCNE1 channels
Several hypothesis have been proposed to explain the electrophysiological differences between acute and long-term administration of PUFAs. Some authors explain PUFA effects by a direct interaction between fatty acid and the ion channel. This hypothesis is supported by the observation that substitutions of a single amino acid in the Na v 1.5 channel diminished the inhibitory effect of acutely administered EPA. 33 Our results showing differences between EPA and DHA effects on K v 7.1/KCNE1 channels are consistent with a direct effect between PUFAs and ion channels. However, their effects were not washed-out and thus, we cannot rule out an indirect effect. Others suggest that PUFA effects are the result of an alteration of the membrane properties rather than a direct interaction with the ion channel. It was reported that PUFAs alter the composition and order of the plasmalema. 12 In this line of evidence, it has been proposed that the potency of PUFAs to inhibit cardiac I Na is correlated with their ability to increase membrane fluidity measured by steady-state fluorescence anisotropy. 34 In addition, changes in cellular redox status, metabolism of phospholipids, and modulation of gene expression are other processes, implying PUFAs that might modulate indirectly ion channel function. 35 To further explore the mechanisms by which acute and chronic PUFAs exert their actions on K v 7.1/KCNE1 channels, three different approaches were used. First, the effects of chronic administration of EPA were analysed on the expression levels of K v 7.1 and KCNE1. In addition to their ability to modulate the electrophysiological properties of ion channels, it was reported that PUFAs decrease the expression levels of K v 1.5 channels. 19 Our data showed that long-term administration (48 h) of PUFAs decreased the protein levels of K v 7.1, but not those of KCNE1, in a concentration-dependent manner. It was established that internalization and stability of K v 7.1 is regulated through ubiquitinylation by Nedd4-2 and posterior degradation in the proteasome. 27 The decreased K v 7.1 expression was prevented by a proteasome inhibitor, suggesting that PUFAs promote K v 7.1 degradation via proteasome. Secondly, targeting of K v 7.1/KCNE1 to lipid rafts during chronic administration of PUFAs was analysed. K v 7.1 channels partially target lipid rafts in ventricular myocytes, 28 whereas KCNE1 localizes in low-buoyancy fractions only in association with K v 7.1. 22 Our results demonstrated that chronic administration of EPA and DHA delocalized K v 7.1 in the cell membrane. This suggests an indirect effect of chronic application PUFAs on channel properties, through a change in its membrane environment. It has been proposed that lipid rafts form signalling platforms in which ion channels, regulatory subunits, scaffolding proteins, kinases, and other modulatory proteins interact. 36 Differential targeting of K v 7.1 and KCNE1 subunits to lipid rafts might represent a critical mechanism of spatial regulation of channel properties as described for other ion channels. 29, 37 Correlated changes in K v 7.1 and KCNE1 location in specific microdomains and in their functional properties were shown in the third set of experiments: lipid raft disruption, triggered by MbCD, was followed by measurements of K v 7.1/KCNE1 current, before and after acute application of EPA. Lipid raft disruption (via membrane cholesterol depletion) increased the current magnitude of K v 7.1/KCNE1 at potentials positive to +30 mV and shifted the activation curve towards positive potentials. This observation emphasizes the impact of membrane environment on channel properties. Most importantly, in these conditions, acute EPA application produced similar effects than those observed in non-cholesterol-depleted cells. This suggests a direct effect of EPA during acute application. Chronic EPA shifts the activation curve to positive potentials, similar to that observed after MbCD treatment. Hence, at least some of the electrophysiological changes on K v 7.1/KCNE1 current after the chronic treatment with EPA might be due to a different location of both subunits on the plasma membrane microdomains. The precise mechanism involved in lipid raft modulation of channel activity is not fully understood. Three different explanations have been proposed: (i) by affecting the biophysical properties of the membrane. Lipid rafts represent thicker and less fluid parts of the membrane than non-raft domains. Changes in the membrane fluidity may modulate ion channel activity. Indeed, it has been described that TRPM8 channel agonists, such as menthol, geraniol, and monoterpenes, enhance the membrane fluidity and increase the ion current. 29 Conversely, increasing the order of the membrane after enrichment with cholesterol inhibits K v 11.1 and K v 7 currents. 38 We can speculate that the location of K v 7.1 and KCNE1 subunits in a thicker and less deformable membrane will increase the energy required for the transition from the closed to the open state. (ii) By specific lipid-protein interactions occurring at raft microdomains. A growing number of studies have demonstrated that cholesterol and PIP 2 , major components of the lipid rafts, modulate the activity of several ion channels. 39 -41 Moreover, it has been recently reported the binding site for fatty acids in the cavity of the prokaryotic potassium channel KcsA. 42 (iii) By protein -protein interactions. Lipid rafts are enriched in multiple signalling molecules such as G-proteins, protein kinases, phosphatases, etc. It was reported that inhibition of K v 7 channels by cholesterol involves the activity of PKC. 43 Following this reasoning, an impaired interaction between K v 7.1/KCNE1 with adjacent proteins could have an effect on the current magnitude. These three mechanisms are not mutually exclusive. Overall, our results suggest that PUFAs act on Kv7.1/KCNE1 channels following two mechanisms: (i) a direct one on the channel protein and (ii) an indirect one through rupturing lipid rafts. given the limited role that I Ks has in modulating repolarization under basal physiological conditions. This AP modification per se is not likely to have pro-or antiarrhythmic significance. But, the I Ks gain of function could play a relevant role when all the contrasting PUFA effects on cardiac electrophysiology are taken into account. Because such effects are not completely characterized in a quantitative way, we only considered, as a proof of concept, a concomitant I Kr reduction. In this condition, acute PUFA exposure seems to play a significant protective role, by partially compensating the AP prolongation.
Clinical implications
On the other hand, the AP simulations also show that chronic exposure to PUFAs does not affect APD 90 , so that the protective role seems lost in this condition. On the contrary, under extreme I Kr inhibition conditions (80% block), EPA exacerbates the lengthening of the APD. This is a potentially important issue, since it was demonstrated that PUFAs decrease I Kr by 75%. 18 PUFA antiarrhythmic effects are controversial and some of the reasons contributing to this variability might be the following. First, at the cellular level, PUFAs modify ion channel function through different mechanisms: (i) directly through specific interactions, (ii) modifying the ion channel levels of expression, and (iii) indirectly after rupturing lipid rafts. Secondly, at the population level, different ways of administration and different doses could influence the variability observed in many clinical trials. Other parameters, such as life style or the total amount of fat ingestion, would also modify the risk of cardiovascular events. Finally and more important, it has been demonstrated that PUFA antiarrhythmic potential depends on the subjacent arrhythmogenic mechanism, being antiarrhythmic in triggered activity-induced arrhythmias but deleterious in re-entry arrhythmias.
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